|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 42692 |
FusionGeneSummary for ZDHHC20_UBIAD1 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ZDHHC20_UBIAD1 | Fusion gene ID: 42692 | Hgene | Tgene | Gene symbol | ZDHHC20 | UBIAD1 | Gene ID | 253832 | 29914 |
| Gene name | zinc finger DHHC-type containing 20 | UbiA prenyltransferase domain containing 1 | |
| Synonyms | 4933421L13Rik|DHHC-20|DHHC20 | SCCD|TERE1 | |
| Cytomap | 13q12.11 | 1p36.22 | |
| Type of gene | protein-coding | protein-coding | |
| Description | palmitoyltransferase ZDHHC20probable palmitoyltransferase ZDHHC20zinc finger DHHC domain-containing protein 20 | ubiA prenyltransferase domain-containing protein 1transitional epithelia response proteintransitional epithelial response protein 1 | |
| Modification date | 20180523 | 20180526 | |
| UniProtAcc | Q5W0Z9 | Q9Y5Z9 | |
| Ensembl transtripts involved in fusion gene | ENST00000400590, ENST00000320220, ENST00000382466, ENST00000542645, ENST00000415724, ENST00000422251, ENST00000494731, | ENST00000376810, ENST00000376804, | |
| Fusion gene scores | * DoF score | 8 X 5 X 6=240 | 2 X 2 X 2=8 |
| # samples | 10 | 3 | |
| ** MAII score | log2(10/240*10)=-1.26303440583379 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(3/8*10)=1.90689059560852 | |
| Context | PubMed: ZDHHC20 [Title/Abstract] AND UBIAD1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | ZDHHC20 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation | 29326245 |
| Hgene | ZDHHC20 | GO:0018345 | protein palmitoylation | 23034182 |
| Tgene | UBIAD1 | GO:0042371 | vitamin K biosynthetic process | 20953171 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChiTaRS3.1 | DA568045 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + | ||
| ChiTaRS3.1 | AK074487 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| intron-3UTR | ENST00000400590 | ENST00000376810 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-intron | ENST00000400590 | ENST00000376804 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-3UTR | ENST00000320220 | ENST00000376810 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-intron | ENST00000320220 | ENST00000376804 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-3UTR | ENST00000382466 | ENST00000376810 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-intron | ENST00000382466 | ENST00000376804 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-3UTR | ENST00000542645 | ENST00000376810 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-intron | ENST00000542645 | ENST00000376804 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-3UTR | ENST00000415724 | ENST00000376810 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-intron | ENST00000415724 | ENST00000376804 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-3UTR | ENST00000422251 | ENST00000376810 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-intron | ENST00000422251 | ENST00000376804 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-3UTR | ENST00000494731 | ENST00000376810 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
| intron-intron | ENST00000494731 | ENST00000376804 | ZDHHC20 | chr13 | 21987859 | - | UBIAD1 | chr1 | 11346838 | + |
Top |
FusionProtFeatures for ZDHHC20_UBIAD1 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ZDHHC20 | UBIAD1 |
| Catalyzes palmitoylation of Cys residues on targetproteins (PubMed:27153536, PubMed:29326245). Catalyzespalmitoylation of Cys residues in the cytoplasmic C-terminus ofEGFR, and modulates the duration of EGFR signaling by modulatingpalmitoylation-dependent EGFR internalization and degradation(PubMed:27153536). Has a preference for acyl-CoA with C16 fattyacid chains (PubMed:29326245). Can also utilize acyl-CoA with C14and C18 fatty acid chains (PubMed:29326245).{ECO:0000269|PubMed:27153536, ECO:0000269|PubMed:29326245}. | Prenyltransferase that mediates the formation ofmenaquinone-4 (MK-4) and coenzyme Q10. MK-4 is a vitamin K2isoform present at high concentrations in the brain, kidney andpancreas, and is required for endothelial cell development.Mediates the conversion of phylloquinone (PK) into MK-4, probablyby cleaving the side chain of phylloquinone (PK) to release 2-methyl-1,4-naphthoquinone (menadione; K3) and then prenylating itwith geranylgeranyl pyrophosphate (GGPP) to form MK-4. Also playsa role in cardiovascular development independently of MK-4biosynthesis, by acting as a coenzyme Q10 biosynthetic enzyme:coenzyme Q10, also named ubiquinone, plays a important antioxidantrole in the cardiovascular system. Mediates biosynthesis ofcoenzyme Q10 in the Golgi membrane, leading to protectcardiovascular tissues from NOS3/eNOS-dependent oxidative stress.{ECO:0000269|PubMed:20953171, ECO:0000269|PubMed:23374346}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for ZDHHC20_UBIAD1 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for ZDHHC20_UBIAD1 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for ZDHHC20_UBIAD1 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for ZDHHC20_UBIAD1 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | UBIAD1 | C0271287 | Schnyder crystalline corneal dystrophy | 7 | CTD_human;HPO;ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|